No profile data available.
Ligand Pharmaceuticals Incorporated (LGND) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in Jupiter, United States, with about 47 full-time employees.
It reported revenue of $268.09 million for fiscal year 2025, up 60.4% from fiscal year 2024, and net income of $124.45 million. Its market capitalization was $6.02 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
Ligand Pharmaceuticals reported $268.09 million in revenue for fiscal year 2025, up 60.4% from $167.13 million in fiscal year 2024.
$6.02 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Dr. Reddy's Laboratories Limited (RDY), Ionis Pharmaceuticals, Inc. (IONS), Amneal Pharmaceuticals, Inc. (AMRX), Crispr Therapeutics AG (CRSP).